Citation Impact
Citing Papers
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response
2016
Methods for evaluation of platelet function
2009 StandoutNobel
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Acute kidney injury
2012 Standout
Platelet pharmacogenomics
2010
Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel
2006
Large early variation of residual platelet reactivity in Acute Coronary Syndrome patients treated with clopidogrel
2015 StandoutNobel
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)*
2005
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
New Antithrombotic Drugs
2008
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Antiplatelet Drugs
2011
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease
2005
Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100
2007
Delayed Graft Function in the Kidney Transplant
2011
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
2008
Acute kidney injury
2019 Standout
Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function
2006
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
2010 Standout
Neutrophil extracellular traps in immunity and disease
2017 Standout
Acute kidney injury
2021 Standout
Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)—its relation to metabolic control
2004
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Oxidative stress in chronic kidney disease
2018 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
In-vitro assessment of platelet function
2011
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Aspirin resistance
2006
The genetics of antiplatelet drug resistance
2008
Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
2005
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Low-dose ASA Response Using the PFA-100 in Women With High-risk Pregnancy
2009
Failure of the Platelet Function Assay (PFA)-100 to detect antiplatelet agents
2015
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
2017 Standout
Thromboelastography: Potential bedside tool to assess the effects of antiplatelet therapy?
2006
Measuring antiplatelet drug effects in the laboratory
2007
Oxidative stress in kidney transplantation: causes, consequences, and potential treatment.
2011
The Role of Aspirin in Cardiovascular Prevention
2008
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Aspirin Resistance and Atherothrombotic Disease
2005
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Works of Laurent Macchi being referenced
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
2002
Monitoring of the Antiplatelet Drugs Effect in Patients with Coronary Artery Disease: What is the Real Clinical Impact?
2007
Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphisms
2003
Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease
2002
Aspirin Resistance: Definitions, Mechanisms, Prevalence, and Clinical Significance
2005
Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular Atrophy
2010